Gary Zieziula
Director/Miembro de la Junta en INNOVENT BIOLOGICS, INC. .
Fortuna: 23 851 $ al 30/04/2024
Cargos activos de Gary Zieziula
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INNOVENT BIOLOGICS, INC. | Director/Miembro de la Junta | 31/05/2022 | - |
| Independent Dir/Board Member | 31/05/2022 | - |
Historial de carrera de Gary Zieziula
Antiguos cargos conocidos de Gary Zieziula.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2014 | - |
| Presidente | - | 01/09/2018 | |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/04/2010 | 04/11/2011 |
| MERCK & CO., INC. | Ventas & Marketing | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Ventas & Marketing | - | - |
Formación de Gary Zieziula.
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Islas Caimán | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 2 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Gary Zieziula
- Experiencia